Plant Health Care signs deal with Arysta for sugar cane protein technology

Biological product provider Plant Health Care has signed an agreement with Arysta LifeScience for the use of its protein technology for foliar sugar cane application in Brazil.Sugarcane is an important crop in Brazil, much of which is used in ethanol production for use in renewable fuels.Under the agreement, Arysta LifeScience will evaluate the protein technology across a range of geographical locations throughout Brazil. The testing program will generate information on the product's capability to increase biomass and sucrose production in sugar cane crops.The product will first go on sale in 2017, provided test results are in line with expectations.Arysta LifeScience's head of marketing Paula Pinto said: "We are excited about the opportunity to expand the organization's portfolio in sugarcane,""The addition of the proprietary protein technology will provide sugarcane farmers the opportunity to significantly increase yield and sugar production in ratoon cane."The group's share price rose 3.38% as of 9:08 on Friday to 122.50p per share.